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Edited by Roger ColbranIn murine and bovine photoreceptors, guanylate cyclase–
activating protein 2 (GCAP2) activates retinal guanylate cy-
clases (GCs) at low Ca2+ levels, thus contributing to the Ca2+/
cGMP negative feedback on the cyclase together with its
paralog guanylate cyclase–activating protein 1, which has the
same function but different Ca2+ sensitivity. In humans, a
GCAP2 missense mutation (G157R) has been associated with
inherited retinal degeneration (IRD) via an unknown molecular
mechanism. Here, we characterized the biochemical properties
of human GCAP2 and the G157R variant, focusing on its
dimerization and the Ca2+/Mg2+-binding processes in the
presence or absence of N-terminal myristoylation. We found
that human GCAP2 and its bovine/murine orthologs signifi-
cantly differ in terms of oligomeric properties, cation binding,
and GC regulation. Myristoylated GCAP2 endothermically
binds up to 3 Mg2+ with high affinity and forms a compact
dimer that may reversibly dissociate in the presence of Ca2+.
Conversely, nonmyristoylated GCAP2 does not bind Mg2+ over
the physiological range and remains as a monomer in the
absence of Ca2+. Both myristoylated and nonmyristoylated
GCAP2 bind Ca2+ with high affinity. At odds with guanylate
cyclase–activating protein 1 and independently of myr-
istoylation, human GCAP2 does not significantly activate
retinal GC1 in a Ca2+-dependent fashion. The IRD-associated
G157R variant is characterized by a partly misfolded, molten
globule-like conformation with reduced affinity for cations and
prone to form aggregates, likely mediated by hydrophobic in-
teractions. Our findings suggest that GCAP2 might be mostly
implicated in processes other than phototransduction in hu-
man photoreceptors and suggest a possible molecular mecha-
nism for G157R-associated IRD.
The phototransduction cascade in vertebrates is finely
regulated by the subtle changes in intracellular Ca2+, which
follow the closure of cyclic nucleotide–gated (CNG) channels
upon the light-induced activation of the 30,50- cGMP phos-
phodiesterase 6 (PDE) (1). Guanylate cyclase–activating* For correspondence: Daniele Dell’Orco, daniele.dellorco@univr.it.
© 2021 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for
BY license (http://creativecommons.org/licenses/by/4.0/).proteins (GCAPs) are among the neuronal calcium sensors
(NCSs) that permit such fine regulation and tune the light
sensitivity of rods and cones, thus contributing to shape their
photoresponses (1, 2). The widely established function of
GCAPs is the regulation of the membrane-bound guanylate
cyclases (GCs) via a Ca2+-dependent feedback mechanism that
renders the enzymatic activity dependent of intracellular
[Ca2+] (3). GCAPs constitutively interact with their GC targets
(4–6) and are able to detect changes in intracellular [Ca2+]. In
the low intracellular Ca2+ phase, when CNG channels are
closed because of PDE-mediated cGMP depletion, GCAPs
stimulate the production of cGMP. When cGMP levels are
sufficiently high, CNG channels reopen, restoring the sub-
micromolar Ca2+ levels typical of dark-adapted cells. Finally,
GCAPs switch to a Ca2+-bound, GC-inhibiting state, bringing
the catalytic activity down to or below the basal levels (1, 7).
GCAPs share a high degree of sequence identity, and the
available three-dimensional structures of three isoforms
(8–10) call for high structural similarity among the homologs.
The general fold is typical of the EF-hand domain pair family,
where two globular domains (N- and C-terminal) made of two
EF-hand motifs are flanked to each other. The three functional
EF-hand motifs permit the binding of up to three cations,
either Ca2+ or Mg2+, in the specific region defined by the helix-
loop-helix motif (see Fig. 1A for a structural model of gua-
nylate cyclase–activating protein 2 [GCAP2]). Up to three
GCAPs isoforms have been discovered in mammal photore-
ceptors, and six to eight in teleost fish (11), thus raising the
question as to the physiological meaning of such apparent
redundancy. GCAPs display different affinity for Ca2+ (12) and
are able to replace Ca2+ with Mg2+ (13–15), thus switching
between different signaling states as a consequence of specific
allosteric mechanisms (16, 17).
The best-known ubiquitous isoforms are guanylate cyclase–
activating protein 1 (GCAP1) and GCAP2, which are present
both in rods and cones and whose biochemical and physiological
features in murine and bovine photoreceptors have been deeply
characterized (18–22). Both GCAP1 and GCAP2 form dimers
under physiological conditions (23, 24), and their concerted ac-
tion is required for the correct Ca2+-dependent cGMP synthesis.J. Biol. Chem. (2021) 296 100619 1
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Figure 1. Three-dimensional structure of nmGCAP2 and assessment of the molecular mass of GCAP2 variants by MALDI-TOF MS. A, Cartoon
representation of the homology model of human nmGCAP2 (built on bovine nmGCAP2 template, PDB entry 1JBA (8)), colored in a red-to-purple rainbow
according to the sequence. Ca2+ are displayed as red spheres, and IRD-associated R157 variant is shown as white sticks with N atoms highlighted in blue. EF1
to EF4 are labeled, together with residue R157. The protein view is rotated by 90 clockwise along the x-axis in the right panel. MALDI spectra of (B)
nmGCAP2, (C) mGCAP2, and (D) G157R with the molecular mass corresponding to each peak. GCAP2, guanylate cyclase–activating protein 2; IRD, inherited
retinal dystrophy; mGCAP2, myristoylated GCAP2; nmGCAP2, nonmyristoylated GCAP2.
Molecular properties of human GCAP2According to an established relay model in rods (7, 25), GCAP1
has lower affinity for Ca2+ and is thus the first GCAP switching to
a GC activator as the light-induced drop in calcium levels de-
velops. GCAP2, which has higher affinity for Ca2+, activates the
GC later in time or at lower Ca2+ levels, thus shaping the recovery
kinetics of the photoresponse in brighter light or after the peak
amplitude under dim light conditions (7). This model has been
confirmed by several lines of evidence in bovine (4, 26) and
murine studies (22) and is therefore thought to be valid for hu-
man photoreceptors. Besides their established activity in the
regulation of the phototransduction cascade in murine and
bovine photoreceptor outer segments, GCAP1 and GCAP2 have
also been localized in the synaptic layer (18, 19), especially sug-
gesting for GCAP2 a Ca2+-dependent mediation of the synaptic
ribbon plasticity (27).
Although to date more than twenty mutations in the gene
GUCA1A encoding for GCAP1 have been associated with
autosomal dominant cone dystrophy or cone–rod dystrophy
(28–39), only one relatively rare missense mutation substituting
Gly157 for an arginine (indicated from now on with G157R) has
been found in GUCA1B encoding for GCAP2 in Japanese
familieswith a history of retinitis pigmentosa, in some caseswith
macular involvement (40, 41). The mutation affects a highly
conserved residue in the EF4 loop (Fig. 1A), compatible with a
decrease in the affinity for Ca2+ of that binding site. The mutant2 J. Biol. Chem. (2021) 296 100619has been studied in vivo by expressing the bovine equivalent to
humanG157R as a transgene in amousemodel of rods GCAP1/
2 KO (42). The study revealed that the mutation caused a sig-
nificant retention of GCAP2 in the inner segment, which is
thought to result in photoreceptor cell death and severe retinal
degeneration (42, 43).
To date, no comprehensive biochemical investigation of the
molecular properties of human GCAP2 has been performed
and no evaluation of the alterations of such properties brought
by the G157R variant was available. In this work, we present a
thorough characterization of the structural and functional
properties of human GCAP2 and its inherited retinal dystro-
phy (IRD)-associated G157R variant.Results
MS analyses
NCS proteins are subjected to a post-translational modifi-
cation where a fatty acid (typically myristic acid) is covalently
bound to the N-terminal Gly, thus conferring the protein-
specific features such as membrane binding or modulation of
the Ca2+ sensitivity (44, 45). To evaluate the effect of myr-
istoylation on structure–function properties of human
GCAP2, we expressed and purified both myristoylated and
nonmyristoylated variants and assessed the presence of the
Molecular properties of human GCAP2post-translational modification by MALDI-TOF MS. The
theoretical molecular mass (MM) of nonmyristoylated GCAP2
(nmGCAP2), based on the canonical protein sequence (Uni-
Prot entry: Q9UMX6), is reported in Table S1, which also
reports the predicted MM of the myristoylated variant (myr-
istoylated GCAP2 [mGCAP2]) both without and with the Gly-
to-Arg substitution (G157R). The difference in the main peaks
detected by MALDI-TOF spectra for mGCAP2 and
nmGCAP2 (212.2 Da) is compatible with the effective myr-
istoylation of the protein. Noticeably, no band ascribable to
nmGCAP2 was visible in the mGCAP2 MALDI-TOF spec-
trum (Fig. 1B), thus pointing to a very efficient myristoylation
process.
The same analysis performed on the G157R variant showed
in a peak at 23.7 kDa (Fig. 1D), compatible with a Gly-to-Arg
mutation and successful myristoylation, as judged by the
substantial correspondence between measured peaks and
theoretical values (Table S1). Interestingly, MALDI-TOF
spectra showed the presence of dimeric forms in samples of
all variants (Fig. 1, B–D and Table S1).
Oligomeric state and aggregation propensity of GCAP2
variants
NCS proteins are characterized by heterogeneous oligo-
meric states (23), and it has been reported that the bovine
GCAP2 undergoes Ca2+-dependent dimerization (46). We
investigated whether a similar behavior could be observed forFigure 2. Effects of Mg2+ and Ca2+ on the apparent molecular mass and t
40-μM (A) nmGCAP2 and (B) mGCAP2 in the presence of 500-μM EGTA + 1-m
estimation by DLS of 40-μM (C) nmGCAP2 and (D) mGCAP2 in the presence o
dynamic light scattering; GCAP2, guanylate cyclase–activating protein; mGC
exclusion chromatography.its human ortholog. By performing analytical size-exclusion
chromatography (SEC) in the presence of Mg2+ or Ca2+ on
both myristoylated and nonmyristoylated forms, we assessed
the effect of cation binding and the post-translational modi-
fication on the oligomeric state. The elution profiles of
nmGCAP2 showed a main peak at 15.2 ml in the presence of
Mg2+, which shifted to 14 ml in the concomitant presence of
Ca2+ (Fig. 2A), thus resulting in an estimated MM of 25 and
58 kDa, respectively (see Experimental procedures). On the
other hand, SEC profiles of mGCAP2 (Fig. 2B) displayed a
cation-independent elution peak at 14.7 ml, corresponding to a
MM of 35 kDa, which could be related to a different oligo-
meric state of the protein in Mg2+ or Ca2+ saturating
conditions.
Dynamic light scattering (DLS) conveniently allows
measuring the change in the hydrodynamic diameter of cal-
cium sensor proteins resulting from the structural rearrange-
ment upon cation binding, as well as to evaluate any potential
time-dependent aggregation propensity by monitoring the
mean count rate (MCR) along the time. Results from DLS
experiments showed an increase of the hydrodynamic diam-
eter upon Ca2+ binding for both GCAP2 forms (Fig. 2, C and
D), although to a different extent. Indeed, nmGCAP2 exhibited
a 0.79-nm increase in the hydrodynamic diameter (6.71 versus
7.50 nm, Table 1, p-value < 0.001), whereas mGCAP2 dis-
played a 1.06-nm increase upon Ca2+ binding (6.02 versus
7.08 nm, Table 1, p-value < 0.001). Nevertheless, such increasehe hydrodynamic diameter of GCAP2 variants. Analytical SEC profiles of
M Mg2+ (blue) or 1-mM Mg2+ + 500-μM Ca2+ (red). Hydrodynamic diameter
f 500-μM EGTA + 1-mM Mg2+ (blue) or 1-mM Mg2+ + 500-μM Ca2+ (red). DLS,
AP2, myristoylated GCAP2; nmGCAP2, nonmyristoylated GCAP2; SEC, size-
J. Biol. Chem. (2021) 296 100619 3
Table 1
Hydrodynamic diameter estimation of GCAP2 variants
Protein State d ± σ (nm) [n] PdI ± σ
nmGCAP2 Mg2+ 6.71 ± 0.08 [39] 0.37 ± 0.08
Mg2+ + Ca2+ 7.50 ± 0.15 [41] 0.31 ± 0.04
mGCAP2 Mg2+ 6.02 ± 0.06 [55] 0.28 ± 0.04
Mg2+ + Ca2+ 7.08 ± 0.10 [38] 0.30 ± 0.03
d, hydrodynamic diameter; n, number of measurements; PdI, polydispersity index; σ,
standard error.
Molecular properties of human GCAP2in the hydrodynamic diameter can be ascribable to a confor-
mational change rather than to an aggregation process, as
shown by the stability of the MCR over the 90-min experi-
mental time (Fig. S1). Interestingly, in the absence of cations,
mGCAP2 displayed an abrupt increase in the MCR and wide
oscillations around an approximately 40% higher value
compared with the Mg2+ or Ca2+ saturating conditions,
without evidence of aggregation trends (Fig. S1) at odds with
nmGCAP2 that, in the apo-form, showed very stable and low
MCR values, indicative of a particularly stable colloidal sus-
pension. The same experiments performed with the IRD-
associated G157R variant did not allow the estimation of the
hydrodynamic diameter because of the high polydispersity
index (0.44 ± 0.07 < polydispersity index <0.54 ± 0.08) of the
colloidal suspension, indicative of a high tendency to rapidly
form aggregates and/or of low protein stability.
Ca2+- and Mg2+-dependent dimerization of mGCAP2
To investigate the dimerization process of the physiologi-
cally relevant myristoylated form of GCAP2 in the presence of
cations, the analytical SEC profiles of mGCAP2 were collected
at an increasing protein concentration. In the presence of the
physiological concentration of Mg2+, the elution peak dis-
played a minor shift of the apparent mass from 31.9 kDa at
5 μM mGCAP2 to 34.3 kDa at concentrations higher than
10 μM (Fig. 3A). On the other hand, in the presence of both
Mg2+ and Ca2+, the main elution peak shifted compatibly with
an increase of mass from 24 kDa (at 5 μM) to 33.8 kDa at 80-
μM mGCAP2 (Fig. 3B), moreover, each peak displayed aFigure 3. Effects of Mg2+ and Ca2+ on mGCAP2 dimerization. Analytical ge
(green), and 80-μM (orange) mGCAP2 in the presence of (A) 500-μM EGTA +
molecular mass as a function of the mGCAP2 concentration together with the
guanylate cyclase–activating protein 2; mGCAP2, myristoylated GCAP2.
4 J. Biol. Chem. (2021) 296 100619shoulder at higher MM with the intensity proportional to the
protein concentration. By fitting the apparent MM as a func-
tion of the mGCAP2 concentration to a hyperbolic curve
(Fig. 3, inset), it was possible to obtain a cation-specific
apparent KD of dimerization. Indeed, in the presence of
Mg2+ mGCAP2 was found to dimerize with an apparent KD <
1 μM (R2= 0.89), thus suggesting that with physiological
[Mg2+] in conditions of very low [Ca2+] mGCAP2 is a dimer.
On the other hand, in the presence of both Mg2+ and Ca2+, the
estimated apparent KD of dimerization shifted to 55.4 μM (R
2=
0.99), thus pointing toward a Ca2+-dependent dimerization of
mGCAP2.
The same experiments performed on G157R showed that,
despite having the same nominal concentration, all chro-
matographic profiles (Fig. S2) were considerably lower in in-
tensity than the WT. Such decrease in absorbance pointed
toward a massive cation-independent aggregation process,
which would render the chromatograms collected at > 20 μM
protein almost undetectable, in line with the behavior observed
in DLS measurements.
Stability and conformational changes of GCAP2 variants upon
metal cation binding
CD spectroscopy can be used to monitor the conformational
changes of NCS proteins upon metal binding, by exploiting the
differential absorption of circularly polarized light of the chiral
centers of the protein. Specifically, the CD signal in the near
UV (250–320 nm) arises from the microenvironment of aro-
matic residues, thus representing a fingerprint of the protein
tertiary structure, whereas in the far UV (200–250 nm), the
optically active peptide bonds provide information about the
secondary structure elements.
The near-UV CD spectrum of apo-nmGCAP2 (Fig. 4A,
black trace) showed a relatively intense positive signal in all
three bands corresponding to aromatic residues (Phe, Tyr, and
Trp), indicating that the protein is significantly structured even
in the absence of ions. No significant changes in either in-
tensity or fine structure could be observed after the addition of
Mg2+ (Fig. 4A, blue trace), while Ca2+ binding resulted in al-filtration chromatograms of 5-μM (black), 10-μM (red), 20-μM (blue), 40-μM
1-mM Mg2+ and (B) 1-mM Mg2+ + 500-μM Ca2+. Insets show the apparent
optimal fitting to a hyperbolic curve (see Experimental procedures). GCAP2,
Figure 4. Conformational changes of GCAP2 variants upon cation binding monitored by CD spectroscopy. Near-UV CD spectra of 30-μM (A)
nmGCAP2, (B) mGCAP2, and (C) G157R in the presence of 500-μM EGTA (black) and after addition of 1-mM Mg2+ (blue) and 1-mM Ca2+ (red). Far-UV CD
spectra of 8-μM (D) nmGCAP2, (E) mGCAP2, and (F) G157R in the presence of 300-μM EGTA (black) and after addition of 1-mM Mg2+ (blue) and 600-μM Ca2+
(red). GCAP2, guanylate cyclase–activating protein 2; mGCAP2, myristoylated GCAP2; nmGCAP2, nonmyristoylated GCAP2.
Molecular properties of human GCAP2prominent reshaping of the spectrum, as shown by the in-
crease in ellipticity, particularly in the dichroic bands of Tyr
and Trp residues (Fig. 4A, red trace). Conversely, apo-
mGCAP2 exhibited an almost flat spectrum (Fig. 4B, black
trace) with a nearly detectable fine structure, while the addi-
tion of Mg2+ caused a significant increase in ellipticity in all
aromatic bands accompanied by a defined fine structure
(Fig. 4B, blue trace), suggesting that Mg2+ is required for the
correct folding of mGCAP2. Finally, Ca2+ addition resulted in
a slight decrease in intensity in the Phe band and a more
prominent increase in ellipticity in the Trp band compatible
with a small but significant conformational change.
Quite surprisingly, the near-UV CD spectra of the G157R
variant were flat under all tested conditions (Fig. 4C); more-
over, to exclude that this observation could result from the
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mGCAP2 EGTA 0.83
Mg2+ 0.84
Mg2+ + Ca2+ 0.89
G157R EGTA 1.24
Mg2+ 1.19
Mg2+ + Ca2+ 1.21
Δθ222/θ222 is calculated as (θ222
ion-θ222
EGTA)/θ222




20.concentration (30 μM), the same experiments were repeated
with halved concentration, yielding the same results.
As far as the secondary structure is concerned, all three
GCAP2 variants exhibited the typical spectrum of an all α-
helix protein (Fig. 4, D–F), with minima at 208 and 222 nm.
The addition of Mg2+ to apo-nmGCAP2 resulted in a minor
increase in ellipticity at 222 nm (Δθ222/θ222 = 6.2%, Table 2)
with no changes in the spectral shape (θ222/θ208 = 0.81 in both
cases, Table 2). A larger effect was exerted by the addition of
Ca2+, which resulted in an 18.3% increase in ellipticity at
222 nm accompanied by a significant reshaping of the spec-
trum (θ222/θ208 = 0.90, Table 2). On the other hand, mGCAP2
displayed a noticeable increase in CD signal upon Mg2+
binding (Δθ222/θ222 = 10.7%, Table 2) while leaving substan-
tially unaltered the spectral shape (θ222/θ208 = 0.83 versus 0.84,










denaturation profiles to a 4-parameter Hill sigmoid. The percentage of unfolding is
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Figure 5. Cation-dependent thermal stability of GCAP2 variants monitored by CD spectroscopy. Thermal denaturation profiles of 8-μM (A) nmGCAP2,
(B) mGCAP2, and (C) G157R in the presence of 300-μM EGTA (black), 300-μM EGTA + 1-mM Mg2+ (blue) and 1-mM Mg2+ + 600-μM Ca2+ (red). When possible,
profiles were fitted to a 4-parameter Hill sigmoid, yielding the Tm values reported in Table 2. GCAP2, guanylate cyclase–activating protein 2; mGCAP2,
myristoylated GCAP2; nmGCAP2, nonmyristoylated GCAP2.
Molecular properties of human GCAP2binding affected both the ratio between the typical minima
(θ222/θ208 = 0.89, Table 2) and the intensity, although the in-
crease in ellipticity was smaller than that of nmGCAP2 (Δθ222/
θ222 = 7.8%, Table 2). Surprisingly, the G157R variant exhibi-
ted the typical shape (Fig. 4F) of a coiled-coil secondary
structure in the absence of ions, as shown by θ222/θ208 = 1.24
(Table 2), which shifted to 1.19 upon addition of Mg2+, with
negligible effects on the intensity of the spectrum. On the
contrary, the addition of Ca2+ resulted in a major increase in
ellipticity (Δθ222/θ222 = 18.0%, Table 2), with minor changes in
the spectral shape, as θ222/θ208 = 1.21.
To assess the thermal stability of the three GCAP2 variants,
the protein secondary structure was followed by heating the
samples up to 96 C. The analysis of the thermal denaturation
profiles highlighted that Mg2+ destabilized nmGCAP2 with
respect to the apo-form (ΔTm = −3.9 C, Table 2), although no
clear transition from a folded to an unfolded state could be
identified in the presence of Ca2+ (Fig. 5A). Similarly, the
thermal stability of mGCAP2 (Fig. 5B) was also slightly
decreased in the presence of Mg2+ (ΔTm = −0.6 C, Table 2). It
is noteworthy, however, that mGCAP2 was significantly less
stable than nmGCAP2 both in the absence (ΔTm = −8.9 C)
and presence of Mg2+ (ΔTm = −5 C). Again, mGCAP2 also
did not exhibit complete unfolding upon Ca2+ binding up to
96 C, but a significantly higher percentage of the protein pool
was denatured at 96 C, with respect to nmGCAP2 (unfolding
47.5% versus 36%, Table 2). The IRD variant G157R was found
to be the least stable in all tested cases (Fig. 5C), although the
presence of Mg2+ slightly increased the thermal stability
compared with the apo-form (ΔTm = 0.9 C). Nonetheless,
neither G157R showed a complete unfolding transition in the
presence of Ca2+ (Fig. 5C), although 59.4% of the ellipticity
signal was lost at 96 C (Table 2).
To probe the stability of the GCAP2 variants with a different
methodology, we assessed their sensitivity to enzymatic pro-
teolysis (47) in different cation-loading states, which permits a
comparative evaluation of conformational and flexibility
changes resulting from Mg2+ or Ca2+ binding (48). We used
nmGCAP2 to probe the proteolytic patterns as a function of
the incubation time with trypsin (Fig. S3), with complete
digestion observed after 30 min of the metal-bound forms.6 J. Biol. Chem. (2021) 296 100619This was at odds with the metal-free form, which presented a
native band even after 1 h, indicative of a substantially different
conformation of the protein in the apo-state compared to the
cation-bound state. To evaluate the cation-dependent pro-
teolytic profiles of all three GCAP2 variants, 10-min incuba-
tion time was chosen for comparisons (Fig. 6).
All three variants displayed the residual presence of native
protein in the absence of ions (Fig. 6, EDTA lanes) and two
major bands at 12 and 9 kDa. Moreover, nmGCAP2
showed a double band between 12 and 15 kDa, which was less
pronounced in the other two variants. In the presence of Mg2+,
the proteolytic pattern was similar in all cases, with faint bands
at lower MM and nmGCAP2 showing a trace of the double
band observed in the apo-form, which was absent in the
myristoylated case (Fig. 6, Mg2+ lanes). Upon Ca2+ addition,
the native band was again detectable in all GCAP2 variants;
moreover, mGCAP2 exhibited a number of proteolytic frag-
ments clustered in the 12- to 15-kDa region, while the
pattern of both nmGCAP2 and G157 spread over a broader
range of MM, with more abundant smaller-sized fragments,
especially for the nmGCAP2 case (see bands at around and
below 10 kDa). Overall, limited proteolysis experiments
confirmed that the effects of Ca2+ on GCAP2 conformation
and trypsin accessibility depend strongly on peculiar proper-
ties of each variant.
Hydrophobic properties of GCAP2 variants differ upon metal
cation binding
GCAPs are hydrophobic molecules (12, 49), a prerequisite
for their capability to constitutively bind their GC targets (50).
We analyzed how the surface hydrophobicity of the three
GCAP2 variants was affected by the presence of metal cations
by monitoring changes in the fluorescence emission of 8-
anilinonaphthalene-1-sulfonic acid (ANS), which binds to
solvent-exposed hydrophobic residues.
ANS-fluorescence measurements highlighted that all three
GCAP2 variants were highly hydrophobic, as shown by the
major increase in fluorescence emission and the blue shift
exhibited by the ANS probe in the presence of the proteins
(Fig. 7). In line with near-UV CD spectra, nmGCAP2 did not
show any changes upon Mg2+ addition (Fig. 7A), either in
Figure 6. Conformational changes of GCAP2 variants upon ion binding assessed by proteolytic cleavage. Limited proteolysis of GCAP2 variants after
10-min incubation with trypsin (60:1 molar ratio) in the presence of 1-mM EDTA, 500-μM EGTA + 1-mM Mg2+, or 1-mM Mg2+ + 1-mM Ca2+. GCAP2,
guanylate cyclase–activating protein 2; mGCAP2, myristoylated GCAP2; nmGCAP2, nonmyristoylated GCAP2.
Molecular properties of human GCAP2terms of intensity or shift (ΔImax/Imax = 0.4%, Table S2) or the
wavelength of maximal emission. Ca2+ binding to nmGCAP2
was found to expose a larger hydrophobic surface, as ΔImax/
Imax = 67.1% (Table S2). In line with CD spectroscopy and at
odds with nmGCAP2, mGCAP2 exhibited sensitivity (Fig. 7B)
to both Mg2+ (ΔImax/Imax = 19.7%, Table S2) and Ca
2+ (ΔImax/
Imax = 88.4%, Table S2). It is noteworthy that ΔImax/Imax for
mGCAP2 resulted to be the highest value among the three
variants analyzed. The same experiments conducted on G157R
suggested that at 2-μM concentration, the IRD-associatedFigure 7. Variations in hydrophobicity of GCAP2 variants upon cation bind
and 2-μM (A) nmGCAP2, (B) mGCAP2, and (C) G157R in the presence of 500-μM
Ca2+ (red). The spectrum of ANS is shown as a green dashed line in panel A. AN
protein 2; mGCAP2, myristoylated GCAP2; nmGCAP2, nonmyristoylated GCAPvariant is significantly more hydrophobic than the WT, both
in the absence and in the presence of cations (Fig. 7C). Thus, in
line with DLS and analytical SEC measurements, these results
suggest that the G157R mutant may be susceptible to aggre-
gation mediated by hydrophobic interactions.
Ca2+- and Mg2+-binding properties strongly depend on
myristoylation
NCS proteins are known to be subjected to differential
electrophoretic mobility in SDS-PAGE experiments undering investigated by ANS fluorescence. Fluorescence spectra of 30-μM ANS
EGTA (black) and after sequential additions of 1-mM Mg2+ (blue) and 1-mM
S, anilinonaphthalene-1-sulfonic acid; GCAP2, guanylate cyclase–activating
2.
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Molecular properties of human GCAP2different cation-loading conditions, as their Ca2+-bound forms
migrate at a lower MM (51). The reason for such phenomenon
is not completely understood, but it has been observed that
Ca2+ sensors change their electrophoretic mobility in a way
that is proportional to their Ca2+ affinity, with those binding
Ca2+ more tightly displaying more prominent shifts (12).
Interestingly, nmGCAP2 and especially mGCAP2 showed
smeared bands in the apo-form, with MM ranging from
23.6 kDa (theoretical mass) to <18 kDa, suggesting high Ca2+
affinity (Fig. 8, EDTA lanes), whereas the G157R variant
exhibited a more compact smear, pointing toward a reduced
affinity for Ca2+. The addition of Mg2+ led to the presence of a
prominent band with a higher apparent MM (Fig. 8, Mg2+
lanes), whereas addition of Ca2+ confirmed the typical shift to a
lower apparent MM of NCS proteins. Indeed, Ca2+-bound
nmGCAP2 presented a single band at a lower apparent MM, at
odds with both WT and G157R mGCAP2, which presented
two separate bands.
To investigate the thermodynamic properties of Mg2+ and
Ca2+ binding to GCAP2 variants, we performed isothermal
titration calorimetry (ITC) measurements by titrating apo-
mGCAP2/nmGCAP2 with Mg2+ or Ca2+. Ca2+ titrations
were also repeated in the presence of physiological levels
(1 mM) of free Mg2+. Proteins were carefully decalcified ac-
cording to a recently optimized protocol (37, 52), which is a
crucial step considering the submicromolar affinity of GCAPs
for Ca2+ (12, 53). Interestingly, when performing Mg2+Figure 8. Effects of Mg2+ and Ca2+ on the electrophoretic mobility of GCA
EDTA, 5-mM EGTA + 1-mM free Mg2+, or 1-mM Mg2+ + 1-mM Ca2+. GCAP
nmGCAP2, nonmyristoylated GCAP2.
8 J. Biol. Chem. (2021) 296 100619titrations with apo-nmGCAP2, a basically flat isotherm was
observed (Fig. 9A). The lack of net change in heat might result
from compensating ΔH terms arising from binding and
conformational change processes. However, the results ob-
tained with ANS fluorescence (Fig. 7A) and near-UV CD
(Fig. 4A) exclude conformational changes and rather suggest
no binding of Mg2+ or a high-millimolar affinity binding,
which would be undetectable with ITC measurements and of
no physiological relevance. On the other hand, Ca2+ titrations
performed with apo-nmGCAP2 (Fig. 9B) showed an
exothermic pattern, which could be fitted only to a two-
sequential binding site model with affinities in the low and
mid nanomolar range (35.2 and 500.5 nM, respectively,
Table 3). We cannot exclude that, in spite of the accurate
decalcification procedure, the third binding site was already
occupied by a Ca2+ because of the presence of 80- to 200-nM
Ca2+ in the decalcified ITC buffer. Ca2+ binding to apo-
nmGCAP2 was found to be entropy-driven for both resolved
binding sites, as shown by the higher contribution of the
entropic term −TΔS (−8.1 and −8.6 kcal/mol, Table 3) with
respect to the enthalpic term ΔH (−2.1 and −0.05 kcal/mol,
Table 3). Interestingly, the same titrations performed in the
presence of 1-mM Mg2+ (Fig. 9C) yielded lower affinities for
both resolved binding sites, as the apparent dissociation con-
stants were 3- to 4-fold higher (109.3 versus 35.2 nM, and 2.1
versus 0.5 μM, Table 3), compatible with an electrostatic
screening effect induced by Mg2+. Similar to the titrations inP2 variants. SDS-PAGE of 20-μM GCAP2 variants in the presence of 5-mM
2, guanylate cyclase–activating protein 2; mGCAP2, myristoylated GCAP2;
Figure 9. Metal cations binding to GCAP2 variants measured by ITC. Representative ITC titrations of 20-μM nmGCAP2 (A–C) and mGCAP2 (D–F). Mg2+ ti-
trations of (A) nmGCAP2 and (D) mGCAP2. Ca2+ titrations of (B) nmGCAP2 and (E) mGCAP2 in the absence and in the presence (C) and (F) of 1-mM Mg2+. Upper
panels show heat pulses, and lower panels represent molar enthalpy changes relative to each injection. When possible, data were fitted to a two- or three-
sequential binding sites (see Experimental procedures), yielding apparent dissociation constants (KD), enthalpy changes (ΔH), and entropy changes (−TΔS) re-
ported in Tables 3 and 4. GCAP2, guanylate cyclase–activating protein 2; ITC, isothermal titration calorimetry; mGCAP2, myristoylated GCAP2; nmGCAP2, non-
myristoylated GCAP2.
Table 3
Thermodynamic parameters for Ca2+ binding to nmGCAP2 in the absence (top) and in the presence of 1-mM Mg2+ after fitting ITC data to a
two sequential binding site model (mean ± SD, n = 3–4)
nmGCAP2 Ca2+ titration (2-site model)
Apparent dissociation constant KD Enthalpy change ΔH (kcal/mol) Entropy change −TΔS (kcal/mol)
KD
1 (nM) KD
2 (nM) ΔH1 ΔH2 −TΔS1 −TΔS2
No Mg2+
35.2 ± 10.4 500.5 ± 273.5 −2.1 ± 0.2 −0.05 ± 0.31 −8.1 ± 0.3 −8.6 ± 0.6
With 1-mM Mg2+
109.3 ± 95.5 2.1 ± 0.6 −2.5 ± 0.2 −2.4 ± 0.5 −7.1 ± 0.7 −5.4 ± 0.6
Molecular properties of human GCAP2
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Table 4
Thermodynamic parameters for Mg2+ binding to mGCAP2 after fitting ITC data to a three-sequential binding site model (mean ± SD, n = 2)
mGCAP2 Mg2+ titration (3-site model)




3 (μM) ΔH1 ΔH2 ΔH3 −TΔS1 −TΔS2 −TΔS3
0.72 ± 0.13 8.6 ± 0.7 10.2 ± 1.9 15.20 ± 0.14 0.02 ± 0.76 8.6 ± 0.8 −23.6 ± 0.3 −4.43 ± 0.10 −15.4 ± 0.7
Molecular properties of human GCAP2the absence of Mg2+, Ca2+ binding to nmGCAP2 was found to
be exothermic and entropy driven, with the main difference
being the enthalpically more favorable binding to the second
site in the presence of Mg2+ (−2.4 kcal/mol versus −0.05 kcal/
mol, Table 3).
In stark contrast with nmGCAP2, titrations of mGCAP2
were compatible with a high-affinity Mg2+-binding process
with an endothermic pattern (Fig. 9D). Data could be fit to a
three-sequential binding site model yielding apparent disso-
ciation constants ranging from 8.6 nM to 10.2 μM (Table 4),
thus suggesting complete saturation under physiological Mg2+
levels. Interestingly, binding was found to be endothermic for
the two binding sites with the lowest affinity (ΔH = 15.2 and
8.6 kcal/mol, respectively, Table 4), while the highest affinity
binding site exhibited a variation in enthalpy close to 0. In
addition, Mg2+ binding to mGCAP2 was entropy driven for all
three binding sites, as was the case for Ca2+ binding to
nmGCAP2, with entropic contribution spanning between −4.3
and −23.6 kcal/mol.
Although Ca2+ titrations of mGCAP2 were qualitatively
reproducible both in the absence (Fig. 9E) and presence of 1-
mM Mg2+ (Fig. 9F), both titration curves showed an inflection
point that significantly exceeded the number of functional
binding sites of a mGCAP2 monomer (3 potential binding
sites). Thus, data fitting to either a two- or three-binding site
model yielded no reasonable values for apparent dissociation
constant, enthalpy, and entropy changes. A possible explana-
tion of such unusual behavior may rise from the analysis of
analytical SEC (Fig. 3B) and near-UV CD (Fig. 4B) data, which
showed that mGCAP2 undergoes both dimerization and
conformational changes upon Ca2+ binding, therefore making
impossible to dissect the different contributions to heat vari-
ation. With this notion in mind, ITC data suggest the transi-
tion from apo-, monomeric mGCAP2 to Ca2+-loaded, dimeric
mGCAP2 to be exothermic. Of note, the molar ratio corre-
sponding to the saturation of the process shifted from
6(Ca2+/mGCAP2) in the absence of Mg2+ to >10 in the
presence of 1-mM Mg2+, suggesting that the high affinity forTable 5
Comparison of GC1 regulation by GCAP1 and GCAP2 variants
Protein
cGMP production (pmol/min) [n]
Low Ca2+ High Ca2+
Control 1.14 ± 0.05 [2] 1.12 ± 0.04 [2]
mGCAP1 39.5 ± 3.8 [3] 2.0 ± 0.5 [3]
mGCAP2 4.6 ± 0.2 [2] 4.3 ± 0.4 [2]
nmGCAP2 6.2 ± 0.6 [3] 6.0 ± 0.5 [3]
G157R 1.3 ± 0.1 [3] 0.68 ± 0.03 [3]
Data are reported as mean ± SD, and n represents the number of independent technical
replicas.
10 J. Biol. Chem. (2021) 296 100619Mg2+ exhibited by mGCAP2 may result in a competition be-
tween the two metal cations, thus decreasing its affinity for
Ca2+.
GC regulation
The main isozyme of the membrane-bound GC, present
both in cones and rods, is GC1 (54) (also referred to as GC-E,
ROS-GC1, or RetGC1), and the other GC2 isozyme is pro-
ducing less than 30% of cGMP in the murine retina (22) and is
25-fold less abundant than GC1 in bovine rod outer segments
(55). To assess the potential contribution of GCAP2 to pho-
totransduction in human photoreceptors, we therefore char-
acterized the ability of the GCAP2 variants to activate human
GC1 expressed in HEK cells. Our group recently reported that,
at odds with bovine and murine orthologs, human mGCAP2
was not able to significantly regulate GC1 activity in vitro, in
reconstitution experiments that confirmed the capability of
human mGCAP1 to regulate the cyclase (56). A similar result
was independently observed by Wimberg et al. (57) when
reconstituting bovine GCAP2 with human GC1. These authors
found 8- to 9-fold less activation of human GC1 by GCAP2
than by GCAP1.
To confirm this unexpected result, we performed enzymatic
assays, increasing the reaction time with respect to our pre-
vious experiments (10 min versus 5 min) and assessed the
cGMP levels by HPLC (see Experimental procedures). The
comparison of mGCAP1- and mGCAP2-mediated regulation
of GC1 (Table 5) confirmed our previous results (56). At odds
with the behavior of mGCAP1, which was able to activate the
target GC1 at low Ca2+ (34-fold higher than the control) and
bring the activation down to basal levels at high Ca2+ (p-
value < 0.001), the activation of GC1 in the presence of
mGCAP2 was found to be only 3-fold higher than the con-
trol and substantially Ca2+ independent (Table 5). The
maximal activation of GC1 induced by mGCAP2 was not even
12% that of mGCAP1 (Table 5), basically reproducing our
previous data (56). The same assays performed with
nmGCAP2 showed a Ca2+-independent and very mild activa-
tion of GC1 (16% compared with mGCAP1). Finally, the
G157R variant led to activity levels comparable with those of
the controls, thus excluding any relevant activation (Table 5),
although the regulation was Ca2+ dependent (p-value < 0.001).
Discussion
Myristoylation modulates the oligomeric state and the
Mg2+/Ca2+ sensitivity of human GCAP2
Myristoylation has been shown to significantly affect bovine
GCAP1 function by modulating the regulation of GC1 (58) as
Molecular properties of human GCAP2well as Ca2+ affinity and protein stability (53). Myristoylation
was also found to influence GCAP1 intracellular location, as
nmGCAP1 was retained in the inner segment of murine
photoreceptors (42). Conversely, myristoylation of bovine
GCAP2 significantly affected neither the ability to regulate
GC1 nor the catalytic efficiency of the enzyme (4, 58).
We previously showed that myristoylation of bovine GCAP2
may affect its structural properties in a rather complex manner
(17). Indeed, in spite of the extremely high sequence identity
(84.5%), some apparent differences become obvious when
comparing the structural response to cations of bovine and
human GCAP2. Although near-UV CD spectra of bovine
mGCAP2 and nmGCAP2 were similarly affected by the pres-
ence of Mg2+ (17), the human ortholog showed a significant
structural response only in the case ofmGCAP2 (Fig. 4,B andE),
in line with the high-affinity binding demonstrated also by ITC
(Fig. 9 and Table 3) and ANS fluorescence (Fig. 7). Indeed,
human mGCAP2 displayed a way more prominent response to
Mg2+ starting from the apo-form (Fig. 4, B–E), which appeared
essentially less structured compared with the nmGCAP2
variant. The latter had already a more defined tertiary structure
in the absence of cations (Fig. 4, A–D) but did not show sig-
nificant Mg2+-induced conformational change.
Another important discrepancy between bovine and human
orthologs regards the thermodynamic characteristics of Mg2+
binding to nmGCAP2 and mGCAP2. In line with the present
study (Fig. 9A), for bovine nmGCAP2, no ITC pattern
compatible with Mg2+ binding was observed starting from the
apo-form. However, variable and puzzling results were
observed for bovine mGCAP2 (17) because only less than half
of the ITC experiments showed patterns compatible with
binding, and when observed, the patterns were exothermic
(17). This is at odds with current data on human mGCAP2,
which showed highly reproducible endothermic Mg2+ binding
with a 3:1 cation:protein stoichiometry and affinities compat-
ible with full saturation in cellular conditions (Fig. 9, Table 4).
Therefore, a subtle link between myristoylation and response
to Mg2+ exists for human GCAP2, but not for the bovine
ortholog.
Bovine mGCAP2 was previously shown to undergo Ca2+-
dependent dimerization (46) and a more recent study using
sedimentation equilibrium estimated a KD = 52 μM for the
monomer/dimer equilibrium in the presence of saturating
Ca2+ (24). To our knowledge, neither of those studies focused
on the potential role of Mg2+ and myristic moiety on the
dimerization process. We investigated this aspect in the pre-
sent study and found that the myristic moiety is crucial for
determining the oligomeric state of human GCAP2. Indeed, in
the absence of Ca2+ and in the presence of physiological levels
of Mg2+, nmGCAP2 was monomeric (Fig. 2A), but in the same
conditions, the myristoylated form promptly shifted to a dimer
(Fig. 1B). Therefore, mGCAP2 present in the photoreceptor
outer segment under conditions of very low Ca2+ corre-
sponding to intense illumination would likely be a dimer
(Fig. 3A). However, under Ca2+-saturating conditions, such as
those typical of dark-adapted cells, a clear equilibrium between
monomeric and dimeric forms was observed (Fig. 3B). Ouranalytical SEC data quantitatively match the finding in Pet-
telkau et al. (24) that GCAP2 forms dimers under saturating
Ca2+ conditions (KD = 55.4 μM), and this evidently occurs also
in the copresence of Mg2+. While the copresence of monomers
and dimers is in principle possible for all the tested variants, as
highlighted by MALDI-TOF measurements (Fig. 1B), a com-
plex relationship between cation levels and myristoylation
evidently determines the actual oligomeric state of human
GCAP2 in specific signaling conditions.
Thermal denaturation studies suggest that Mg2+ slightly
destabilizes mGCAP2 (Table 2), but the destabilization is
more significant for nmGCAP2 (Table 2). Instead, Ca2+
binding stabilized all the GCAP2 variants, but the lowest
degree of thermal unfolding was observed for nmGCAP2
(Table 2), which apparently does not bind Mg2+ as
confirmed by ITC and CD spectroscopy (Figs. 9A and 4A).
Analysis of the proteolytic patterns for nmGCAP2 (Fig. S3)
seems to apparently contradict thermal denaturation pro-
files, as under the tested conditions, the apo-form was the
one less prone to protease digestion, whereas in conditions
of saturating Mg2+ or Ca2+, the trypsin cleavage was
completed rather soon. However, the contradiction is only
apparent, as the proteolytic method is only indirectly related
to stability, as it is rather sensitive to protein conformation.
Indeed, nmGCAP2 was clearly already structured in the
absence of cations (Fig. 4A), in contrast to apo-mGCAP2,
which appeared to show a much lower degree of tertiary
structure (Fig. 4B) also confirmed by the oscillations of the
hydrodynamic diameter observed in time-resolved DLS
(Fig. S1B) pointing to a dynamic molten globule state rather
than to an aggregation-prone conformation.
The specificity and peculiarity of the signaling states of m-
and nm-human GCAP2 is reflected by the hydrodynamic size
of the two variants, which increased upon addition of Ca2+ to
a different extent (Table 1, Fig. 2, C and D) indicative of
specific hydrodynamic and hydrophobic properties also
revealed by ANS fluorescence (Fig. 6). Both variants indeed
bound Ca2+ on top of Mg2+, although with specific patterns
(Fig. 9). It is extremely difficult to estimate reliable binding
constants for mGCAP2 by ITC, likely due to the concomitant
dimerization and conformational change processes whose
specific enthalpic contribution cannot be dissected. A similar
phenomenon was already observed for bovine mGCAP2 (17).
Probably, only high-resolution analytical techniques such as
titrations performed by NMR could help solving individual
equilibria, thus providing robust KD estimates for Ca
2+
binding to each site.
In conclusion, our characterization points to myristoyl
acting as a dynamic regulator of human GCAP2 structure and
oligomeric state, which allows more prominent and sensitive
structural response to Mg2+ and Ca2+ stimuli. Structural in-
formation on bovine GCAP2 showed that, at odds with
GCAP1, the myristic moiety could be rather exposed to the
solvent in both apo-state and Ca2+-bound state (59). This is
proved by its noticeable sensitivity to the external environ-
ment, as confirmed by experiments with membranes and mi-
celles (60). Our data are substantially in line with this view andJ. Biol. Chem. (2021) 296 100619 11
Molecular properties of human GCAP2further underline other discussed peculiarities of human
GCAP2 compared with the bovine ortholog.
The IRD-associated G157R variant is misfolded and tends to
form aggregates independently of Mg2+ and Ca2+
Our in vitro data show that the IRD-associated G157R
variant forms a molten globule state deprived of tertiary
structure (Fig. 4C), yet clearly conserving elements of sec-
ondary structure (Fig. 4F). Surprisingly, the CD spectra showed
features of a coiled-coil assembly that, although less than the
WT, responded to Mg2+ and Ca2+ stimuli (Fig. 4F), as
confirmed by gel shift assays (Fig. 8) and ANS fluorescence
(Fig. 7C). G157R was significantly less stable than the WT
under all tested conditions (Table 2), and a noteworthy ten-
dency to form aggregates was observed independent of the
cations. ANS fluorescence spectra suggest the process to be
triggered by the high exposition of hydrophobic patches (Fig.
7C).
The subcellular distribution of GCAP2 in murine photore-
ceptors was shown to strongly depend on its phosphorylation
state, with the maximal distribution to the rod outer segment
estimated to be approximately 50% (61). According to murine
in vivo studies, a 50% phosphorylation of residue S201 in
bovine GCAP2 (S197 in human GCAP2) causes protein
sequestration at the inner segment, and the accumulation of
GCAP2 variants unable to bind cations in the inner segment
induced severe toxicity (61). The equivalent of G157R for
bovine GCAP2 (G161R), expressed as a transgene in mice
lacking GCAPs, caused the retention of 80% GCAP2 in the
inner segment in more than half of the tested cells (42). The
mutation also altered the Ca2+ dependence of S201 phos-
phorylation by PKG in vitro over Ca2+ levels that mimic those
in photoreceptors (42). Taken together, our data suggest a
parallel between the pathological mechanism in murine and
human retina, and support the hypothesis that a poorly defined
tertiary structure and reduced ability to respond to Ca2+ may
enhance the phosphorylation of the G157R variant, which
might lead to its accumulation and possibly aggregation in the
inner segment, as observed in mouse photoreceptors (42).
Is human GCAP2 mainly involved in the phototransduction
cascade?
Based on robust mathematical models of phototransduction
cascade in amphibian (62) and mouse rods (63), we have
previously proposed that, in the presence of high expression
levels of cone dystrophy–associated GCAP1 mutants blocking
GC1 in a constitutively active state, GCAP2 could compensate
by dynamically regulating the cGMP synthesis (64). The
experimental confirmation of this hypothesis has been recently
reported in vivo in a mouse model where GCAP2 was shown
to contribute to GC1 activation in cones in the absence of
GCAP1 (65). Nonetheless, the minor activation of GC1 by
mGCAP2 and its independence on Ca2+ (Table 5) observed in
the present and previous findings (56) do not support a similar
hypothesis for human photoreceptors. Indeed, it has been
demonstrated in vitro that the presence of human GCAP212 J. Biol. Chem. (2021) 296 100619could not mitigate the dominant effect of the cone–rod dys-
trophy–associated E111V-GCAP1 variant leading to abnor-
mally high synthesis of cGMP at physiological levels of Ca2+,
whereas extra delivery of WT GCAP1 could partly restore the
normal cyclase regulation (56). The data presented in this
work are fully in line with such previous observations and
partly in contrast with those reported in a recent contribution
(66) where human mGCAP2 was shown to activate human
GC1 to approximately half levels compared with GCAP1.
Using an in vitro assay similar to the one presented here, the
authors interpreted the lack of GCAP2-mediated activation of
GC1 reported in our previous work (56) as probably due to a
deficiency in the preparation of functional GCAP2 (66). We
clearly demonstrate in this study that this is not the case, as
recombinant human GCAP2 indeed displays all the
biochemical features of a perfectly functioning NCS protein
switching between different states, moreover recombinant
GCAP1, expressed and purified by a very similar procedure,
was fully capable of activating GC1 (Table 5). Our present data
show that human GCAP2 is a very weak activator of human
GC1 because the observed activity only slightly exceeds that of
the control, as observed previously with bovine GCAP2 (57).
We do not have an explanation for the discrepancy between
our findings and those in Peshenko et al. (66), but it should be
noted that no investigation of the Ca2+ dependence of GC1
activation by GCAP2 was reported in that study; therefore, no
conclusion as to the effective dynamic regulation is currently
possible. Moreover, in the same study, the reported EC50 value
(19 μM) for GCAP2-mediated GC1 activation as a function of
the protein concentration was approximately 17-fold higher
than that observed for human GCAP1 (1.13 μM), indicating a
rather low affinity for the human GCAP2–GC1 complex. If the
cellular concentration observed in bovine rods (approximately
3 μM for both GCAP1 and GCAP2) is taken as a reasonable
reference also for human rods, this would exclude any signif-
icant role of human GCAP2 in regulating human GC1 also
with the data presented in Peshenko et al. (66), at least in the
concomitant presence of GCAP1. Considering the neat prev-
alence of GC1 isozyme as the cyclase involved in the photo-
transduction cascade in many species, our data do not support
a prominent role for GCAP2 in regulating phototransduction
in human photoreceptors.
Alternative roles for human GCAP2
The role of GC2 in human photoreceptors' outer segments
is still unknown, and a GCAP2-mediated activation of GC2
similar to the one observed in bovine (4, 13) and mice rods (22,
25, 67) is still to be proven. It is therefore reasonable to expect
a minor, if any, role of GCAP2 in regulating phototransduction
in human. The possibility that GCAP2 is involved in biological
functions not occurring in the outer segment and therefore
different from the phototransduction cascade indeed dates
back to its discovery (20), mostly supported by the apparent
absence of GCAP2 in photoreceptor outer segments in early
reports. A thorough study corroborated by electron micro-
scopic analysis localized GCAP2 in monkey and human retinas
Molecular properties of human GCAP2in both rods and cones, with a higher localization in inner
segments than outer segments (68). The pattern of retinal
expression of GCAP2 therefore seems to be different between
mice and humans (68), and the exerted biological role could
therefore be distinct in different species. It is also noteworthy
that in various species significant immunoreactivity was
detected for GCAP2, but not GCAP1, in bipolar, amacrine, and
ganglion cells, while both GCAPs were detected in the synaptic
region of the photoreceptors, suggesting again an involvement
in pathways other than regulation of phototransduction (69).
Results from in vivo studies in mice indicate that
GCAP1:GCAP2 relative levels should be preserved for main-
taining the integrity of the synaptic terminal (43) and points to
a specific role of GCAP2 in remodeling morphological changes
of synaptic ribbons. Such process could be mediated by
GCAP2 binding to RIBEYE, a component of the synaptic
ribbon (27), and could confer a Ca2+-dependent plasticity to
synaptic processes that would not necessarily require outer
segment cyclases as a target. These hypotheses should be
specifically tested in future studies, which should also inves-
tigate whether and to what extent can human GCAP2 activate
human GC2.
Experimental procedures
Expression and purification of human WT and G157R GCAP2
The cDNA of human GCAP2 (UniProt entry: Q9UMX6)
was cloned into pET-11a(+) vector using Ndel and NheI as
restriction sites (GenScript). The G157R point mutation was
introduced by site-directed mutagenesis using QuikChange II
Kit (Agilent), and primers (forward: 50-CAGCTGGCCGT
CACGGTTCTCATCAACCA-30, reverse: 50-TGGTTGATG
AGAACCGTGACGGCCAGCTG-30) and DNA sequencing
were obtained by Eurofins. Nonmyristoylated WT GCAP2 was
heterologously expressed in Escherichis coli BL21 DE3 cells
after transformation with pET-11a(+)-GCAP2 plasmid. Myr-
istoylated WT and G157R GCAP2 were heterologously
expressed in E. coli BL21 DE3 cells after cotransformation with
pET-11a(+)-GCAP2 or pET-11a(+)-GCAP2–G157R and
pBB131–yNMT (encoding for N-myristoyl transferase from
S. cerevisiae) plasmids. The expression and purification pro-
tocol for GCAP2 variants was essentially the same as reported
in refs. (4, 70). Briefly, bacteria were grown at 37 C until
absorbance at 600 nm reached 0.7, when protein expression
was induced with 1-mM IPTG, and finally, the bacterial pellet
was collected after 4 h at 37 C. For myristoylated forms,
50 μg/ml myristic acid (in 50% ethanol, pH 7.5) was added at
absorbance at 600 nm = 0.4. After cell lysis, solubilization of
inclusion bodies in 6 M guanidinium hydrochloride, refolding
by dialysis and ammonium sulfate precipitation, GCAP2 var-
iants were purified using a combination of SEC (HiPrep 26/60
Sephacryl S-200 HR, GE Healthcare) and anion-exchange
chromatography (HiPrep Q HP 16/10, GE Healthcare) as
described in Marino et al. (33), with the only difference being
the pH for anion-exchange chromatography buffers (8 for WT,
8.5 for G157R variant). The protein concentration was
measured by the Bradford assay (71), using a calibration curveobtained specifically for human GCAP2 after quantification by
amino acid hydrolysis analysis (Alphalyse). Protein purity was
assessed by SDS-PAGE, and then GCAP2 samples were
exchanged in 20-mM Tris HCl, pH 7.5, 150-mM KCl, and 1-
mM DTT buffer, flash-frozen, and stored at −80 C until use.
MALDI-TOF MS
GCAP2 samples for MALDI-TOF-MS measurements
(1.0 mg/ml in 20 mM Tris HCl pH 7.5, 150 mM KCl, 1 mM
DTT buffer) were desalted by ZipTip C4 (Millipore), and
desalted protein was eluted with 30% (v/v) acetonitrile/0.1%
(v/v) formic acid. First, a sinapinic acid matrix layer was pre-
pared by depositing a droplet (0.5 μl) of saturated solution of
sinapinic acid in 100% ethanol on the target. Thereafter, the
eluted sample was deposited on an MALDI target plate.
MALDI analyses were performed with ultrafleXtreme MALDI-
TOF/TOF MS provided by the "Centro Piattaforme Tecnolo-
giche" of the University of Verona.
Analytical SEC experiments
The apparent MM of GCAP2 variants was determined by
analytical SEC using a Superose 12 10/300GL (GE Healthcare)
column equilibrated with 20-mM Tris HCl, pH 7.5, 150-mM
KCl, 1-mM DTT buffer, and 500-μM EGTA + 1-mM Mg2+
or 500-μM Ca2+ + 1-mM Mg2+.
A calibration curve was obtained as described earlier (72).
Standard proteins for calibration were carbonic anhydrase
(29 kDa), alcohol dehydrogenase (150 KDa), β-amylase
(200 kDa), and cytochrome c (12.4 kDa). The elution profiles
at λ = 280 nm of 40 μMGCAP2 (or in the 5- to 80-μM range
for analytical SEC titrations) were recorded at 25 C to identify
the elution volume (Ve) used to calculate the partition coeffi-
cient (Kav) according to the following equation:
Kav ¼ðVe −VvÞ = ðVt −VvÞ
where Vv is the void volume (8 ml) and Vt is the total column
volume (25 ml). The MM was then extrapolated from the
calibration curve of log(MM) as a function of Kav described in
(72). The apparent dimerization constant was obtained by
fitting the MM as a function of the protein concentration to a
singular rectangular three-parameter hyperbola:
MM¼MM0þa  ½GCAP2bþ½GCAP2
where MM0 represents the Y-intercept, a represents the
asymptotic value for MM minus the Y-intercept, and b is the
apparent KD value obtained by fitting.
DLS measurements
The hydrodynamic diameter and the time evolution of the
MCR of GCAP2 variants were measured with a Zetasizer
Nano-S (Malvern instruments) at 25 C, using the experi-
mental setup detailed in (73). Protein samples were diluted to
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1-mM Mg2+ or 1-mM Mg2+ + 500 μM Ca2+ and filtered
through a 20-nm cut-off Anotop 10 filter (Whatman) before
DLS measurements. Samples were equilibrated at 25 C for
2 minutes, and 38 to 55 measurements were collected
approximately every 2 minutes for >90 min, each consisting of
16 to 18 repetitions.
CD spectroscopy and thermal denaturation profiles
CD data were collected at 37 C on a Peltier thermostated
Jasco J-710 spectropolarimeter using the same parameters as
described previously (33). The spectrum of the buffer (20-mM
Tris HCl, pH 7.5, 150-mM KCl, 1-mM DTT) was recorded
and subtracted to both near- and far-UV CD spectra. Near-UV
CD spectra of 30-μM GCAP2 variants were collected between
250 and 320 nm in 1-cm quartz cuvette in the presence of 500-
μMEGTA, and after sequential additions of 1-mMMg2+ and 1-
mM Ca2+, leading to approximately 500-μM free Ca2+. Far-UV
CD spectra of 8-μMGCAP2 variants were collected in the 200-
to 250-nm range in 1-mm quartz cuvettes in the presence of
300-μM EGTA and after sequential additions of 1-mM Mg2+
and 600-μM Ca2+, leading to approximately 300-μM free Ca2+.
The thermal denaturation profiles were recorded in the
same experimental conditions as far-UV CD spectra on the
same samples using the following parameters: temperature
range 20 to 96 C, scan rate 1 C/min, response time 4 s, and
wavelength 222 nm. Assuming a two-state transition process
where the ellipticity signal as a function of the temperature
represents the fraction of folded/unfolded protein, thermal





Where y0 is the ellipticity value at 20 C, a is the variation in
ellipticity between 96 C and 20 C, b is the Hill coefficient, c is
the inflection point of the sigmoid, which represents the
melting temperature.
SDS-PAGE mobility shift assays
A 15% acrylamide SDS-PAGE was performed to evaluate
the cation-induced differential electrophoretic mobility of
GCAP2 variants under denaturing conditions. Proteins were
diluted in 20-mM Tris HCl, pH 7.5, 150-mM KCl, and 1-mM
DTT buffer to 20 μM and loaded on the gel after 5 min in-
cubation with 5-mM EDTA, 5-mM EGTA +1-mM Mg2+ or 1-
mM Mg2+ + 5-mM Ca2+.
Limited proteolysis
Limited proteolysis of 25-μM GCAP2 variants in the pres-
ence of 1-mM EDTA, 500-μM EGTA +1-mM Mg2+ or 1-mM
Mg2+ + 1-mM Ca2+ was performed after incubation at 25 C
with trypsin in an enzyme:protein molar ratio of 1:60. Enzy-
matic cleavage was stopped after 5, 10, 15, 30, 45, 60, and
90 min through heat inactivation of trypsin, and then, samples14 J. Biol. Chem. (2021) 296 100619were loaded onto a 15% SDS gel (Fig. S3). Proteolytic patterns
reported in Figure 6 refer to 10-min incubation with trypsin.
ITC
Cation binding to GCAP2 variants was monitored by ITC
using a MicroCal PEAQ-ITC (Malvern Instruments) following
the decalcification procedure detailed previously in refs. (37,
52). Briefly, protein samples were dialyzed overnight against
20-mM Hepes, pH 7.4, 60-mM KCl, 4-mM NaCl buffer, and
then buffer and samples were decalcified before ITC mea-
surements with a gravity-packed Chelex 100 (Bio-Rad) col-
umn, resulting in a final free Ca2+ of 80 to 200 nM. Titrations
of 8- to 20-μM nmGCAP2 were performed at 25 C by 40
consecutive injections of 1 μl of 2- to 7-mM Mg2+ or 150-μM
– 1-mM Ca2+ in the absence and in the presence of
1-mM Mg2+. Titrations of 13- to 27-μM mGCAP2 were per-
formed at 25 C by injecting 1 μl of 1- to 2-mM Mg2+ or 1- to
2-mM Ca2+ in the absence and in the presence of 1-mMMg2+.
Injections scheme for each experiment consisted of 150- or
210-s initial delay and 180-s injection space. For each condi-
tion, a minimum of two independent technical repetitions
were obtained and subjected to data fitting after adjusting the
baseline using the fitting offset criterion, thus excluding
enthalpic contributions arising from the dilution of cations
into buffer. Ca2+ titrations of nmGCAP2 were fitted by
MicroCal PEAQ-ITC Analysis Software (Malvern In-
struments) to a two-sequential binding site model, although no
binding was identified in Mg2+ titrations. Mg2+ titrations of
mGCAP2 were fitted by MicroCal PEAQ-ITC Analysis Soft-
ware (Malvern Instruments) to a three-sequential binding site
model. Data fitting yielded estimated values for dissociation
constants (KD
i) and enthalpy variations (ΔHi) for each (i)
binding site. Data in Tables 3 and 4 are presented as the
average ± SD of 2 to 4 independent technical repetitions.
ANS–fluorescence spectroscopy
Fluorescence spectra were collected at 37 C with a Jasco FP
750 spectrofluorometer, with excitation and emission band-
widths set to 5 nm; each reported spectrum is an average of
three accumulations.
The hydrophobic fluorescent probe ANS was diluted to
30 μM in 20-mM Tris HCl, pH 7.5, 150-mM KCl, 1-mM DTT
buffer and incubated for 2 min with 2-μM GCAP2 variants.
Emission fluorescence spectra were recorded in the 400 to
650-nm range after excitation at 380 nm in the presence of
500-μM EGTA and after sequential additions of 1-mM Mg2+
and 1-mM Ca2+.
GC activity assays
Recombinant human guanylate cyclase 1 (GC1, alternatively
GC-E, ROS-GC1, or RetGC1) was coexpressed with GFP in
HEK293 cells as reported previously (74) to obtain a stable
expression system. Briefly, fluorescent HEK293–GC cells were
cultured in Dulbecco’s modified Eagle’s medium supplemented
with fetal bovine serum (10%, v/v), penicillin (100 units/ml),
streptomycin (100 μg/ml), and geneticin (500 μg/ml). HEK293
Molecular properties of human GCAP2cells were transfected using branched polyethylenimine
(10 kDa), and transfection was verified byWestern blot analysis.
GC activity was measured after reconstitution of cell mem-
branes as described previously (4, 33). Briefly, GC1 was incu-
bated for 10 min at 30 C with 5-μM GCAP1 (prepared as in
Marino et al. (33)) or mGCAP2/nmGCAP2 or G157R variant
and 1-mM free Mg2+, in the absence (<19 nM) or in the pres-
ence of Ca2+ (30 μM). Production of cGMP was analyzed by
loading the reaction mixture onto a C18 reverse phase column
(Lichrospher 100, RP-18, 5 mm, 250-4 (Merck)). Free Ca2+
concentration was adjusted using Ca2+–EGTA buffer solutions
as described previously (26). Data presented inTable 5 represent
the average ± SD two to three independent technical replicas.
Homology model of human GCAP2
The three-dimensional model of human GCAP2 shown in
Figure 1 (residues 1–186) was built using the software Prime
(Schrödinger, LLC) using the NMR structure of bovine
nmGCAP2 in its Ca2+-bound state as a template (PDB en-
try: 1JBA (8)) following the identification of globally
conserved residues by the HMMER/Pfam algorithm. Loops
were refined by the computational protocol described in
Jacobson et al. (75). In silico mutagenesis to achieve the
G157R substitution was performed using the BioLuminate
suite, and both models (WT and G157R) were energy-
minimized by performing four iterations, each consisting
of 65 steps with root mean square gradient for convergence
set to 0.01 kcal/mol/Å.
Statistical data analysis
The statistical significance of the differences in hydrody-
namic diameter and cGMP synthesis was assessed using a one-
tailed t test (p-value = 0.001), where the null hypothesis was
that the mean of a population was greater than or equal to the
mean of the other population.
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